Etiket: BioNTech
Pfizer and BioNTech shares higher premarket as vaccine approval planned for young children
shares in this article Three vaccinations generated strong immune responses and high effectiveness, said the Mainz-based biotech company BioNTech and the US pharmaceutical company Pfizer on Monday. The two partners…
BioNTech shares, Moderna shares & Co: Headwinds on the stock exchange
funds in this article shares in this article by Julia Groß, Euro am Sonntag BioNTech, Moderna and Novavax had to lose feathers in the past few days. And this despite…
Fake news about Corona: Biontech does not warn against its own vaccine
An error occurred when entering the password. Please check the spelling and try again. Bitte wähle deine Anzeigename. Bitte wählen Sie einen Benutzernamen mit weniger als 256 Zeichen. Bitte trage…
Vaccine Stocks: Here’s Why Moderna and BioNTech Are Passing the Competition
funds in this article shares in this article by Julia Groß, Euro am Sonntag DThe US FDA has approved a fourth dose of their Covid vaccines for Moderna,…
BioNTech, Moderna, Novavax & Co: Which vaccine stocks are now interesting again
shares in this article by Julia Groß, Euro am Sonntag Dhe fourth dose seems to be slowly becoming a reality in more and more developed countries, at least…
BioNTech, Moderna and Valneva: Sentiment on vaccine stocks is brightening
shares in this article ETFs in this article by Julia Gro, Euro on Sunday DThe disturbing news about the sharp rise in corona cases in China has caused shares…
Vaccine company BioNTech makes 10.3 billion euros profit
BioNTech, the German pharmaceutical company that developed a successful corona vaccine together with Pfizer, has made a net profit of 10.3 billion euros in 2021. The turnover amounted to almost…
Valneva, BioNTech & Co: Vaccine Stocks – Risk Aversion
shares in this article by Julia Gro, Euro on Sunday Dhe war has prompted stock markets to flee risky investments, including biotech stocks. Valneva bucked the trend with positive…
Vaccine stocks Novavax, BioNTech, Moderna & Co.: Where strong potential lies dormant
shares in this article by Julia Gro, Euro on Sunday Sanofi and GlaxoSmithkline have presented the final data on their protein-based vaccine and announced that they will apply for…
BioNTech shares, Moderna shares & Co: Vaccine shares are looking for the bottom
shares in this article ETFs in this article by Julia Gro, Euro on Sunday M Some analysts want to see a bottoming out in the biotechnology sector. However,…